S.Amdt. 2585Senate118th Congress (2023-2025)
S.Amdt. 2585
Sponsored by
Sen. Todd Young (R-IN)
Submitted July 11, 2024
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
July 11, 2024
Text
Submitted
SA 2585. Mr. YOUNG (for himself and Mr. Padilla) submitted an amendment intended to be proposed by him to the bill S. 4638, to authorize appropriations for fiscal year 2025 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows: At the end of subtitle E of title XII, add the following: SEC. 1272. REPORT ON INTERNATIONAL COLLABORATION ON DEFENSE BIOTECHNOLOGY RESEARCH AND DEVELOPMENT. (a) Report Required.--Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense, in coordination with the Secretary of State and the Secretary of Commerce, shall submit to the appropriate congressional committees a report detailing any ongoing work with international partners and treaty allies to advance research and development on biotechnology, especially for applications relevant to national defense. (b) Elements.--The report required by subsection (a) shall include the following: (1) A description of the international security partnerships that, as of the date on which the report is submitted, do, or could, include biotechnology research and development for defense, including-- (A) the Five Eyes intelligence alliance; (B) the North Atlantic Treaty Organization (NATO); or (C) any defense cooperation agreement entered into-- (i) with a major non-NATO ally designated under section 517 of the Foreign Assistance Act of 1961 (22 U.S.C. 2321k); or (ii) under section 2350a of title 10, United States Code, or the Foreign Relations Authorization Act, Fiscal Year 2003 (Public Law 107-228). (2) A description of any challenges to collaborative biotechnology research and development, including any challenges that may prevent the partnerships described in paragraph (1) from being leveraged to the fullest extent possible. (3) A description of any limitations on co-investments within those partnerships. (4) An assessment of whether any United States export controls or other technology protections, including the International [[Page S4927]] Traffic in Arms Regulations, are hindering information sharing and cooperation on defense biotechnology research and development. (c) Form.--The report required by subsection (a) shall be submitted in unclassified form, but may include a classified annex. (d) Appropriate Congressional Committees Defined.--In this section, the term ``appropriate congressional committees'' means-- (1) the Committee on Armed Services, the Committee on Foreign Relations, and the Committee on Banking, Housing, and Urban Affairs of the Senate; and (2) the Committee on Armed Services and the Committee on Foreign Affairs of the House of Representatives. ______